tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PCRX Stock Latest News

Doma Perpetual nominates three to Pacira board
The FlyDoma Perpetual nominates three to Pacira board
8d ago
PCRX
Pacira reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Pacira reports inducement grants under Nasdaq listing rule
13d ago
PCRX
Pacira Earnings Call Highlights Margin Gains And Growth
PremiumCompany Announcements
Pacira Earnings Call Highlights Margin Gains And Growth
15d ago
PCRX
Pacira presents evidence real-world evidence from IGOR
PremiumThe Fly
Pacira presents evidence real-world evidence from IGOR
17d ago
PCRX
Pacira: Conservative 2026 Outlook, Margin Discipline, and NOPAIN Act Tailwinds Support Buy Rating
PremiumRatings
Pacira: Conservative 2026 Outlook, Margin Discipline, and NOPAIN Act Tailwinds Support Buy Rating
20d ago
PCRX
Pacira reports Q4 EPS 57c, consensus 90c
PremiumThe FlyPacira reports Q4 EPS 57c, consensus 90c
20d ago
PCRX
Pacira sees FY26 revenue $745M-$770M, consensus $792.23M
Premium
The Fly
Pacira sees FY26 revenue $745M-$770M, consensus $792.23M
20d ago
PCRX
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
23d ago
PCRX
Pacira Biosciences (PCRX) Securities Lawsuit Dismissed by New Jersey Federal Court
PremiumClass Action
Pacira Biosciences (PCRX) Securities Lawsuit Dismissed by New Jersey Federal Court
27d ago
PCRX
Pacira highlights new NOPAIN act survey data conducted by Voices
PremiumThe Fly
Pacira highlights new NOPAIN act survey data conducted by Voices
1M ago
PCRX
Pacira reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Pacira reports inducement grants under Nasdaq listing rule
1M ago
PCRX
Pacira BioSciences adds seasoned leader to board
PremiumCompany Announcements
Pacira BioSciences adds seasoned leader to board
2M ago
8K
PCRX
Pacira appoints Samit Hirawat to board of directors
PremiumThe FlyPacira appoints Samit Hirawat to board of directors
2M ago
BMY
PCRX
Pacira announces agreement with LG Chem
Premium
The Fly
Pacira announces agreement with LG Chem
2M ago
PCRX
Pacira management to meet with H. C. Wainwright
Premium
The Fly
Pacira management to meet with H. C. Wainwright
2M ago
PCRX
Pacira management to meet with H. C. Wainwright
PremiumThe Fly
Pacira management to meet with H. C. Wainwright
2M ago
PCRX
Pacira Biosciences: Exparel-Led Growth and Discounted Valuation Support Attractive Risk–Reward and Buy Rating
PremiumRatings
Pacira Biosciences: Exparel-Led Growth and Discounted Valuation Support Attractive Risk–Reward and Buy Rating
2M ago
PCRX
Pacira: Maintaining Buy on Durable Non-Opioid Growth and Share Buybacks Despite Near-Term Revenue Softness
PremiumRatings
Pacira: Maintaining Buy on Durable Non-Opioid Growth and Share Buybacks Despite Near-Term Revenue Softness
2M ago
PCRX
Closing Bell Movers: AXT Inc. slips after cutting Q4 revenue guidance
PremiumThe Fly
Closing Bell Movers: AXT Inc. slips after cutting Q4 revenue guidance
2M ago
GM
MGM
Pacira reports preliminary FY25 revenue $726.4M, consensus $730.22M
PremiumThe FlyPacira reports preliminary FY25 revenue $726.4M, consensus $730.22M
2M ago
PCRX
DOMA intends to nominate three director candidates at Pacira annual meeting
Premium
The Fly
DOMA intends to nominate three director candidates at Pacira annual meeting
3M ago
PCRX
Pacira Ends Hip Osteoarthritis Injection Study for ZILRETTA: What Investors Should Know
Premium
Company Announcements
Pacira Ends Hip Osteoarthritis Injection Study for ZILRETTA: What Investors Should Know
3M ago
PCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >